J. Charpentier

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici et al. · Nature Medicine · 2018 · 664 citations · Full text

Pathology, Fatty Liver Disease, Obesity +17

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease

Lucile Garidou, Celine Pomié, Pascale Klopp et al. · Cell Metabolism · 2015 · 290 citations · Full text

Dysbiosis, Mucosal Immunology, Host-microbe Interactions +12

A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism

E. Grasset, Anthony Puel, J. Charpentier et al. · Cell Metabolism · 2017 · 265 citations · Full text

Gut-brain Axis Mechanism, Dysbiosis, Mucosal Immunology +14

SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations

Romain Paccoud, Céline Saint-Laurent, Enzo Piccolo et al. · Science Translational Medicine · 2021 · 46 citations

Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion

J. Charpentier, François Briand, Benjamin Lelouvier et al. · Acta Diabetologica · 2021 · 41 citations

Inflammation, Autoimmune Disease, Host-microbe Interactions +11